Yonatan Ayalew Mekonnen

Yonatan Ayalew Mekonnen

Auto-generated profile, based on publicly available information

Yonatan Ayalew Mekonnen

Department of Molecular Oncology, Moffitt Cancer Center, Tampa, FL, United States

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Journal of Hepatology
Verified
Journal Article
Closed access
COCarlos Oltmanns
Carlos Oltmanns
ZLZhaoli Liu
Zhaoli Liu
JMJasmin Mischke
Jasmin Mischke
JTJan Tauwaldt
Jan Tauwaldt
YMYonatan Ayalew Mekonnen
Yonatan Ayalew Mekonnen
MCMarkus Cornberg
Markus Cornberg

15 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
INIsis Y Narvaez-Bandera
Isis Y Narvaez-Bandera
ALAshley Lui
Ashley Lui
YMYonatan Ayalew Mekonnen
Yonatan Ayalew Mekonnen
VRVanessa Rubio
Vanessa Rubio
NSNoah Sulman
Noah Sulman
PSPaul Stewart
Paul Stewart
Summary: Integrative Module Analysis for Multi-omics Data ( iModMix ) is a biology-agnostic framework that enables the discovery of novel associations across any type of quantitative abundance data, including but not limited to transcriptomics, proteomics, and metabolomics. Instead of relying on pathway annotations or prior biological knowledge, iModMix constructs data-driven modules using graphical lasso to estimate sparse networks from omics features. These modules are summarized into eigenfeatures and correlated across datasets for horizontal integration, while preserving the distinct feature sets and interpretability of each omics type. iModMix operates directly on matrices containing expression or abundances for a wide range of features, including but not limited to genes, proteins, and metabolites. Because it does not rely on annotations ( e . g ., KEGG identifiers), it can seamlessly incorporate both identified and unidentified metabolites, addressing a key limitation of many existing metabolomics tools. iModMix is available as a user-friendly R Shiny application requiring no programming expertise ( https://imodmix.moffitt.org ), and as an R package for advanced users ( https://github.com/biodatalab/iModMix ). The tool includes several public and in-house datasets to illustrate its utility in identifying novel multi-omics relationships in diverse biological contexts. Availability and implementation: Shiny application: https://imodmix.moffitt.org . The R package and source code: https://github.com/biodatalab/iModMix .

3 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
YMYonatan Ayalew Mekonnen
Yonatan Ayalew Mekonnen
OOOscar E. Ospina
Oscar E. Ospina
VRVanessa Rubio
Vanessa Rubio
EWEric Welsh
Eric Welsh
RUReaz Uddin
Reaz Uddin
PSPaul Stewart
Paul Stewart
Mass spectrometry imaging (MSI) enables spatially resolved metabolomics in intact tissue sections, but analysis remains challenging at scale. Existing MSI workflows often require users to combine multiple software tools, while others rely on proprietary vendor software that limits interoperability and reproducibility. To address these challenges, we developed spatialMET, an open-source framework that provides an end-to-end workflow for MSI analysis. spatialMET provides a unified platform for preprocessing, spatial domain detection, and visualization. Downstream analyses include differential abundance testing, spatial autocorrelation and gradient analysis, dimensionality reduction, and correlation network analysis. Spatial domain detection uses hcdist, a C-based hierarchical clustering implementation that substantially reduces runtime and memory use relative to existing R-based approaches. spatialMET can be run through an interactive R Shiny application or as a standalone command-line workflow for larger datasets or high-performance computing environments. Applied to mouse small cell lung cancer MALDI-MSI data containing 284,673 pixels, spatialMET identified tumor-associated, stromal, and adjacent lung spatial domains that aligned with matched histology. Differential abundance analysis identified 117 m/z features that differed between tumor and stromal regions, while spatial autocorrelation analyses revealed spatially structured abundance patterns. Applying spatialMET to mouse lung adenocarcinoma data from an entire lung lobe containing 338,477 pixels further demonstrated scalability and captured spatial heterogeneity across tumor and surrounding lung tissue. In summary, spatialMET provides a scalable, open-source framework for end-to-end spatial metabolomics analysis, and it is distributed as a Docker container for reproducible deployment. Source code and installation instructions are available at https://github.com/biodatalab/spatialMET .